Harrow, Inc. Operating Lease, Liability, Noncurrent
Harrow, Inc. (HROW) had Operating Lease, Liability, Noncurrent of $7.42 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability, Noncurrent $7.42M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $7.67M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $7.91M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $8.14M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $7.42M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $7.67M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $7.91M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $8.14M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $8.37M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $8.58M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $8.79M 10-K · filed 2026-03-02 |
| 2024-09-30 | $9.50M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $6.54M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $6.72M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $6.52M 10-K · filed 2025-03-27 |
| 2023-09-30 | $6.74M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $6.94M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $7.14M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $7.33M 10-K · filed 2024-03-19 |
| 2022-09-30 | $7.52M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.70M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $6.82M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.01M 10-K · filed 2023-03-23 |
| 2021-09-30 | $4.62M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.70M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $6.50M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $6.65M 10-K · filed 2022-03-10 |
| 2020-09-30 | $6.78M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $6.03M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $6.21M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $6.34M 10-K · filed 2021-03-08 |
| 2019-09-30 | $5.85M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $5.98M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $6.08M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |